We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
-17.24%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$10.9B
AUM Growth
-$6B
(-36%)
Cap. Flow
-$3.12B
Cap. Flow
% of AUM
-28.68%
Top 10 Holdings %
Top 10 Hldgs %
39.15%
Holding
1,272
New
54
Increased
189
Reduced
877
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares China Large-Cap ETF
FXI
|
+$98.6M |
| 2 |
KraneShares CSI China Internet ETF
KWEB
|
+$28.5M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$23.8M |
| 4 |
Texas Instruments
TXN
|
+$9.35M |
| 5 |
VTNR
Vertex Energy, Inc
VTNR
|
+$8.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$612M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$211M |
| 3 |
Microsoft
MSFT
|
+$102M |
| 4 |
Broadcom
AVGO
|
+$90M |
| 5 |
Qualcomm
QCOM
|
+$84.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.25% |
| 2 | Financials | 12.23% |
| 3 | Energy | 7.74% |
| 4 | Healthcare | 5.49% |
| 5 | Industrials | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Danaher
DHR
$138B
| $4.02M | 0.04% |
17,897
-4,238
| -19% | -$976K |
|
|
BPMC
327
DELISTED
Blueprint Medicines
BPMC
| $4.01M | 0.04% |
79,403
-14,232
| -15% | -$834K |
|
328
Cullen/Frost Bankers
CFR
$10.3B
| $3.97M | 0.04% |
34,109
-22,280
| -40% | -$2.85M |
|
329
HP
HPQ
$24.6B
| $3.97M | 0.04% |
121,169
-62,127
| -34% | -$2.28M |
|
330
Emergent Biosolutions
EBS
$375M
| $3.96M | 0.04% |
127,727
-18,901
| -13% | -$645K |
|
331
Veracyte
VCYT
$4.77B
| $3.96M | 0.04% |
198,981
-25,782
| -11% | -$521K |
|
332
Natera
NTRA
$38.6B
| $3.95M | 0.04% |
111,575
-25,612
| -19% | -$948K |
|
333
Commerce Bancshares
CBSH
$8.55B
| $3.94M | 0.04% |
72,927
-54,520
| -43% | -$3.06M |
|
334
Neurocrine Biosciences
NBIX
$18.7B
| $3.94M | 0.04% |
40,402
-19,494
| -33% | -$1.8M |
|
335
Arcus Biosciences
RCUS
$3.55B
| $3.93M | 0.04% |
155,056
-6,498
| -4% | -$159K |
|
336
Enphase Energy
ENPH
$4.94B
| $3.87M | 0.04% |
19,796
-8,491
| -30% | -$1.53M |
|
|
BHVN
337
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $3.86M | 0.04% |
26,479
-18,522
| -41% | -$2.37M |
|
338
W&T Offshore
WTI
$515M
| $3.84M | 0.04% |
888,915
+461,002
| +108% | +$2.59M |
|
339
Halozyme
HALO
$9.88B
| $3.83M | 0.04% |
87,152
-66,844
| -43% | -$2.89M |
|
340
Loews
L
$23.9B
| $3.83M | 0.04% |
64,672
-40,595
| -39% | -$2.55M |
|
341
Cboe Global Markets
CBOE
$31B
| $3.81M | 0.04% |
33,623
-19,901
| -37% | -$2.23M |
|
342
Cytokinetics
CYTK
$10.9B
| $3.8M | 0.04% |
96,657
-45,945
| -32% | -$1.85M |
|
|
CCXI
343
DELISTED
ChemoCentryx, Inc.
CCXI
| $3.78M | 0.03% |
152,368
-73,036
| -32% | -$1.61M |
|
344
Ironwood Pharmaceuticals
IRWD
$614M
| $3.75M | 0.03% |
324,984
-133,208
| -29% | -$1.57M |
|
345
Prosperity Bancshares
PB
$8.97B
| $3.74M | 0.03% |
54,781
-37,556
| -41% | -$2.58M |
|
|
EXAS
346
DELISTED
Exact Sciences
EXAS
| $3.65M | 0.03% |
92,581
+7,367
| +9% | +$394K |
|
347
Global Payments
GPN
$23.8B
| $3.64M | 0.03% |
32,939
-16,015
| -33% | -$2.03M |
|
348
CRISPR Therapeutics
CRSP
$4.77B
| $3.64M | 0.03% |
59,877
+34,015
| +132% | +$2M |
|
349
Popular Inc
BPOP
$11.2B
| $3.63M | 0.03% |
47,138
-39,711
| -46% | -$3.16M |
|
350
CareDx
CDNA
$1.97B
| $3.61M | 0.03% |
168,209
-5,523
| -3% | -$153K |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q2 2022 Portfolio in Review
As of Q2 2022, Rafferty Asset Management held 1,272 positions worth $10.9B, down 36% from $16.9B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Rafferty Asset Management withdrew a net $3.12B in Q2 2022, closing 147 positions and reducing 877 holdings. Its most notable exit was Xtrackers Harvest CSI 300 China A-Shares ETF, an estimated $24.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Energy.
Against the trend, Rafferty Asset Management opened a new position in Vertex Energy, Inc worth $7.26M.
- Rafferty Asset Management's largest Q2 2022 buy was Vertex Energy, Inc: 690,301 shares worth $7.26M.
- Rafferty Asset Management added most to iShares China Large-Cap ETF in Q2 2022, an estimated $98.6M increase.
- Rafferty Asset Management's biggest Q2 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $612M.
- Rafferty Asset Management fully exited Xtrackers Harvest CSI 300 China A-Shares ETF in Q2 2022, selling an estimated $24.8M.
- Rafferty Asset Management's ten largest holdings make up 39% of its $10.9B portfolio in Q2 2022.
- Rafferty Asset Management opened 54 new positions and closed 147 in Q2 2022.
- Rafferty Asset Management's portfolio value fell 36% quarter-over-quarter to $10.9B.
Based on Rafferty Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.